Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12791283.ece/ALTERNATES/schema-16_9/doc7eok1wt4jdl13ye5emaw.jpg)
Monday
Orphazyme sells entire business to US biotech company
Orphazyme didn’t know buyer before negotiations began
Zealand Pharma CEO hopes for partnership news in coming months
New EU regulation has made the medtech industry turn to the US
Tuesday
Future uncertain for Orphazyme CEO as firm sold
Lundbeck has initiated phase I trial of acquired candidate
Zealand Pharma sells insulin pump to Mannkind Corporation
Obesity rates increase to ”epidemic” level in Europe, WHO warns
Wednesday
In a world of options, Genmab’s CEO chose partnerships
Thursday
Ambu appoints Britt Meelby Jensen new CEO
Novo Holdings establishes new firm managed by biotech veterans
US government exercises option to buy Bavarian smallpox vaccines for USD 119m
Friday
Nine new drugs recommended for approval by CHMP at May meeting
Britt Meelby Jensen wants to rebuild trust in Ambu
Ambu board had started headhunting process long before firing of CEO